Open Access

Decline in transmission of schistosomiasis mansoni in Oman

Infectious Diseases of Poverty20165:112

DOI: 10.1186/s40249-016-0210-1

Received: 4 September 2016

Accepted: 4 December 2016

Published: 12 December 2016

Abstract

Background

Intestinal schistosomiasis due to Schistosoma mansoni was first reported in Oman in 1979. We describe the trend in parasitological and serological prevalence of human infection with S. mansoni in the endemic area over the period 1982–2014, and the compliance of data generated by the national monitoring and evaluation system with schistosomiasis elimination criteria set by the Ministry of Health of Oman.

Methods

Parasitological and serological assessments were carried out on population (mainly children) living in the area at risk for schistosomiasis in Dhofar, the country’s only endemic Governorate, for a period of over 30 years. Kato-Katz thick smear and Indirect Haemagglutination Assay were the techniques employed.

Results

Data indicate a progressive decline in prevalence of S. mansoni throughout the 1980s and the 1990s, a recrudescence in the early 2000s, and a more marked decrease following the implementation of six rounds of mass treatment with praziquantel from 2007 to 2013. Latest parasitological prevalence (2011) was 0%, while latest serological prevalence (2014) was 0.11%.

Conclusion

Transmission of schistosomiasis has reached very low levels in Oman. Elimination criteria established by the Ministry of Health of Oman (parasitological prevalence ≤ 1% and serological prevalence ≤ 5%) have been met since 2008. Further investigations are required to assess whether interruption of transmission has been achieved in some or all foci, in view of the establishment of a formal verification process under the auspices of WHO.

Keywords

Schistosomiasis Schistosoma mansoni Elimination Parasitology Serology Oman

Multilingual abstracts

Please see Additional file 1 for translation of the abstract into six official working languages of the United Nations.

Background

Schistosomiasis and its elimination

Schistosomiasis is a blood-fluke (trematode) infection characterized by two major clinical presentations. Schistosoma mansoni, S. mekongi, S. intercalatum and S. japonicum are responsible for intestinal schistosomiasis, while S. haematobium causes urogenital schistosomiasis [1]. The burden of schistosomiasis is still significant in many parts of the world; however several countries have reached a low-endemic status [2]. Since the adoption of World Health Assembly Resolution WHA65.21 on “elimination of schistosomiasis” [3], and the release of the Schistosomiasis Strategic Plan 2012–2020 [2], WHO encourages low-burden countries to embark in the “final push” and cut transmission of schistosomiasis, thus achieving its elimination, through an inter-sectorial approach encompassing preventive chemotherapy, snail control, environmental management, health education, access to safe water, and sanitation.

As Oman is one of such countries, we aim to describe the trend in levels of parasitological and serological prevalence of human infection with S. mansoni over the period 1982–2014, and we discuss the compliance of data generated by the national monitoring and evaluation system with elimination criteria set by the Ministry of Health of Oman, as well as the steps required to further document interruption of S. mansoni transmission in the country, in view of the expected establishment of a formal verification process to be carried out under the auspices of WHO.

Schistosomiasis in Oman

Both Schistosoma mansoni and Schistosoma haematobium are endemic in the Arabian peninsula, notably in Saudi Arabia and Yemen [4, 5].

In Oman, transmission of intestinal schistosomiasis due to S. mansoni has been documented only in Dhofar Governorate, and was first reported in 1979. Biomphalaria arabica (a strain of B. pfeifferi) has been identified as the snail intermediate host, and since 1896 has been observed in Dhofar, where its distribution is limited to few foci only. Extensive malacological investigations have shown that B. arabica is not present elsewhere in Oman and that no other Biomphalaria species is found in the country, [610] thus excluding the possibility of transmission of S. mansoni outside Dhofar.

Although the snail Bulinus wrighti, a potential intermediate host of S. haematobium, is present in Dhofar [10, 11] as well as in other limited areas of the country [12], transmission of S. haematobium has never been found to occur in Oman, and no autochthonous cases of urinary schistosomiasis have ever reported by the country [13, 14].

Dhofar lies in south-western Oman, bordering Yemen. It is a rather mountainous region covering 99 300 sq km (38 300 sq mi) (Fig. 1), with a population of approximately 375 000. Dhofar’s weather is relatively cool and rainy even during the summer (July to September, e.g., in July, mean daily temperature = 26.4 °C, mean rainfall 24.5 mm). Schistosomiasis transmission sites include temporary and permanent, natural and artificial water bodies and riverbeds (wadis) located in a relatively small (80 km × 20 km), hilly area along the coast of the Indian Ocean [15] (Figs. 2 and 3). Such area lies within 20 km from the seashore, and is comprised in the wilayat (provinces) of Salalah, Taqah and Mirbat. Water contact used to be related to domestic activities but now mainly occurs for recreational purposes, although shepherds might bring their animals to water bodies, thus having occasional contacts. Human population in the area at risk for schistosomiasis is estimated at 25 000, including Omanis and non-Omanis.
Fig. 1

Map of Oman (in red: schistosomiasis endemic area in Dhofar Governorate)

Fig. 2

Natural water body in hilly Dhofar (WHO/AF Gabrielli)

Fig. 3

Artificial water body used for recreational purposes (WHO/AF Gabrielli)

In Dhofar, epidemiology of schistosomiasis has been monitored through an extensive active surveillance screening system. Passive surveillance is also in place; schistosomiasis is a notifiable disease under group B-Communicable Diseases, which means that suspect or confirmed cases detected through the routine health services of Oman have to be reported within a week time [16]. While a few cases of both S. mansoni and S. haematobium infection are still passively detected every year in several Governorates among non-Omanis and Omanis alike, thorough investigations have led to the conclusion that none, among the cases occurred in recent years, acquired the infection in Oman; as such they were all considered imported. The last passively-detected autochthonous case occurred in 2007: a case of intestinal schistosomiasis from Dhofar governorate [14].

Schistosomiasis control in Dhofar

Epidemiological investigations on schistosomiasis, as well as planning of public-health measures to tackle the disease, followed the detection of the first two cases of schistosomiasis, at Sultan Qaboos Hospital in Salalah, in 1979 [15]. Starting in 1982, all water bodies in Dhofar were systematically screened for presence of B. arabica, which revealed presence of the snail in a total of 22 water bodies out of 120, most of which were located in remote mountainous areas, and difficult to reach [17]. An inter-sectorial control strategy was consequently launched in 1983. It included snail control by mollusciciding with niclosamide (Bayluscide®); environmental modification of water bodies (embanking; building public latrines and increasing access to potable water); health education relying on different media channels including notice signs advising the population not to enter water in reason of the risk of schistosomiasis (Fig. 4); and population screening and treatment of positive cases.
Fig. 4

Sign advising not to enter water bodies (WHO/AF Gabrielli)

While transmission appeared largely under control during the 1990s, a recrudescence in 2000–2001 triggered the adoption of a schistosomiasis elimination strategy relying on mass treatment with praziquantel. The strategy was launched by the Ministry of Health in 2003, with support from the World Health Organization. Elimination targets were set by the Ministry of Health of Oman and defined as parasitological prevalence ≤ 1% by Kato-Katz thick smear and serological prevalence ≤ 5% by Indirect Haemagglutinantion Assay (IHA), to be achieved in Dhofar Governorate by 2012 [MoH, unpublished]. Six rounds of mass treatment with praziquantel 40–60 mg/kg targeting children and adults were implemented at approximately annual intervals between April 2007 and September 2013 (treated population ranged between 4 000 and 15 000; see Table 1). Over this period, complementary public-health interventions continued to be implemented but on a lesser scale, although tilapia fish were introduced in some water bodies for biological control of snails. Health education activities consisted in renovating existing notice signs and introducing new ones, and in providing similar messages to children in school (through health education sessions) and adults in health centres (through posters, and health staff’s advice).
Table 1

Mass chemotherapy with praziquantel, 2007 – 2013

Round

Year

Wilayat

Target population

Population treated

1st

April 2007

Salalah

Schoolchildren

4,302

2nd

October 2007

Salalah

Schoolchildren and adults

3rd

2008

Salalah

Schoolchildren and adults

5,148

-

2009

-

Not Implemented

0

4th

2010

Taqah

Schoolchildren and adults

1,760

5th

2011

Salalah, Taqah, Mirbat

Schoolchildren and adults

15,795

6th and final round

2013

Taqah, Mirbat

Schoolchildren and adults

4,960

Methods

From 1982 to 2011, schistosomiasis trends were monitored through active parasitological screenings of population living in the endemic areas (both Omani and expatriates), mainly schoolchildren aged 6–17 years, an exercise that was followed by treatment of positive cases and, from 2007, by the implementation of mass chemotherapy with praziquantel in selected areas.

From 2001 onwards, yearly serological assessments were also implemented among schoolchildren (all Omani). As such, between 2001 and 2011, both stool and serological assessments were carried out. As in 2011 no individuals were found to test positive to stool examination, the Ministry of Health decided to stop parasitological screening and only rely on serological investigations.

Between 1982 and 2011, stool samples were collected by sanitary inspectors and processed at the Governorate Public Health Laboratory in Salalah, the capital city of Dhofar. The technique employed was Kato-Katz thick smear [18].

Serological assessments were conducted among schoolchildren every year between 2001 and 2014. Schools were selected from affected localities in the wilayats of Salalah, Taqah, and Mirbat. The last survey conducted prior to the commencement of mass treatment interventions was implemented in 2007; the last one in 2014, 1 year after the last distribution of praziquantel. The inclusion criteria were (i) 7th grade students (12–14 years old) at the time of the survey; (ii) from schools located in endemic areas in Dhofar Governorate (i.e. from selected localities in the area suspect for active transmission). The exclusion criteria were (i) student not registered in 7th grade, (ii) unwillingness to participate or (iii) impossibility to take blood sample for any reason.

Children recruited in serological monitoring and evaluation activities were asked to provide blood samples for serological screening by IHA [19], with the aim of detecting antibodies against adult S. mansoni worm antigens, and thus documenting both current and past infection (elevated antibody levels are still detectable many years after cure [20]). Blood samples were collected in the field by health personnel and transported to the Governorate Public Health Laboratory in Salalah for processing.

The aim of the stool and serological screening was to monitor trends in epidemiology of schistosomiasis, and, from 2007 (baseline) onwards, to assess the impact of mass chemotherapy with praziquantel over the following years. Active surveillance by population screening was meant to complement passive surveillance implemented through the routine health services of Oman, based on the consideration that the sensitivity of the latter strategy would be too low to detect autochthonous cases of schistosomiasis (who would most likely be asymptomatic and of low intensity of infection in reason of its reduced levels of transmission).

Results

Table 2 and Fig. 5 show numbers screened and testing positive by type of examination, between 1982 and 2014, and the corresponding levels of parasitological and serological prevalence of infection. Overall, a decreasing trend in both parasitological prevalence and seroprevalence of S. mansoni infection was observed among screened individuals in Dhofar Governorate during the period under study.
Table 2

Number of schistosomiasis cases actively detected annually in Dhofar: 1982 – 2014

Year

Stool Examination

Serology Test

Number screened

Omani positive

Non-Omani positive

Total positive

Number screened

Positive (all Omani)

1982

2,038

16

7

23 (1.12%)

--

--

1983

7,278

4

6

10 (0.13%)

 

--

1984

3,880

4

6

10 (0.25%)

--

--

1985

3,352

16

24

40 (1.19%)

--

--

1986

5,663

10

10

20 (0.35%)

--

--

1987

3,977

3

7

10 (0.25%)

--

--

1988

5,642

2

3

5 (0.08%)

--

--

1989

2,739

2

1

3 (0.1%)

--

--

1990

2,645

3

0

3 (0.11%)

--

--

1991

1,500–2,000

0

0

0

--

--

1992

1,500–2,000

0

0

0

--

--

1993

1,500–2,000

0

0

0

--

--

1994

1,500–2,000

0

0

0

--

--

1994

1,500–2,000

0

0

0

--

--

1996

654

2

0

2 (0.3%)

--

--

1997

444

0

0

0

--

--

1998

200

1

0

1 (0.5%)

--

--

1999

168

1

0

1 (0.59%)

--

--

2000

578

13

0

13 (2.24%)

--

--

2001

800

36

0

36 (4.5%)

511

139 (27.2%)

2002

1,237

81

1

82 (6.62%)

305

72 (23.6%)

2003

796

81

0

81 (10.17%)

2 418

287 (11.86%)

2004

748

14

0

14 (1.87%)

3 745

413 (11.02%)

2005

763

15

0

15 (1.96%)

5 633

551 (9.78%)

2006

448

5

3

5 (1.78%)

2 639

42 (1.59%)

2007

165

15

0

15 (9.09%)

3 210

48 (1.49%)

Start of mass treatment with praziquantel

 2008

167

1

0

1 (0.59%)*

9 188

165 (1.79%)

 2009

265

0

0

0

3 024

28 (0.92%)

 2010

246

1

0

1 (0.4%)*

3 265

136 (4.16%)

 2011

109

0

0

0

2 988

63 (2.10%)

 2012

--

--

--

--

2 513

51 (2.02%)

 2013

--

--

--

--

2 788

14 (0.50%)*

 2014

--

--

--

--

3 608

4 (0.11%)*

(*) Statistically-significant reduction from 2007 values

Fig. 5

Decline of parasitological and serological prevalence of infection with S. mansoni in Dhofar

An increase in parasitological prevalence was however observed from the early 2000s, after several years during which the number of detected cases was very small. This finding reflects the reintroduction of transmission in rural areas of Salalah wilayat, a fact confirmed by the detection of infected B. arabica snails in the relevant water bodies, several year after the last specimen had been found [MoH, unpublished]. The causes of such recrudescence remain unclear, although suspicions point either to a rodent reservoir, based on the consideration that Rattus rattus was found to be naturally infected with S. mansoni in Dhofar [17], or to reintroduction of transmission by travellers from neighbouring countries (e.g. Yemen was then highly endemic for S. mansoni). Following the adoption of a mass-treatment-based elimination strategy by the health authorities of Oman, a statistically significant decrease (P < 0.001) in prevalence was observed between 2007 (last stool investigation conducted prior to the start of mass treatment) and the following years (2008–2011). Over such 4-year period, only zero or one cases were detected during each survey, compared to 15 cases in 2007.

Serological trends also show a progressive decrease in prevalence. Notably, the last survey conducted prior to the start of mass chemotherapy, in 2007, indicated that out of 3 210 children serologically screened, 48 were positive (1.49%). In 2014, following the completion of six rounds of praziquantel mass chemotherapy, 3 608 children were serologically tested and only four found to be positive (0.11%). The decrease in prevalence of infection observed between 2007 and 2014 is statistically significant (P < 0.001).

Discussion

A parasitological prevalence ≤ 1% by Kato-Katz and a serological prevalence ≤ 5% by IHA, in 2006 were achieved in Dhofar in 2008 and 2006, respectively. As such, as of 2008, the country is compliant with both national elimination criteria set by the Ministry of Health of Oman (although WHO rather employs the term elimination to refer to the actual interruption of transmission [2]). The irregular but progressive decrease of parasitological prevalence, and the less rapid, but steady decline of serological prevalence of S. mansoni infection in areas at risk in Dhofar reflect the different phases experienced by Oman in its fight against schistosomiasis: the gradual reduction of risk of acquiring new infections in the 1980s–1990s as a probable consequence of the inter-sectorial control measures applied; the recrudescence observed in the early 2000s; and finally the impact on transmission registered from 2007 onwards, as a probable consequence of the implementation of the six rounds of mass treatment conducted until 2013.

Conclusion

Transmission of schistosomiasis has reached very low levels throughout the area at risk in Oman; considering that serological assessments detect both current and past infections, transmission might in fact have been interrupted in some or all foci already. Additional investigations are therefore required to ensure collection of evidence that would sustain the country’s claim that schistosomiasis has been eliminated, and would enable Oman to access the WHO’s formal process to verify interruption of transmission, which is currently being established [A. Garba, personal communication].

In line with other countries which have achieved low transmission of Schistosoma spp. infection, such investigations should be systematically implemented throughout the area at-risk, and should rely on sensitive procedures able to rule out continuing transmission. Such procedures include molecular detection of S. mansoni cercariae in snail intermediate hosts [20], as well as assessment of current infection in human populations, through detection of antigens to S. mansoni (e.g. by circulating cathodic antigen (CCA) tests) [21, 22], or through stool sedimentation coupled with miracidia hatching test [23].

Should transmission of S. mansoni be shown to continue in Dhofar, although at low levels, an aggressive strategy would be required, relying on mass chemotherapy with praziquantel in all remaining foci coupled with a renewed effort on complementary public health interventions such as snail control, environmental management, improved sanitation, safe water supply, and health education. In case of successful verification of the schistosomiasis-free status, post-elimination surveillance would need to be implemented with the aim of detecting any new case and preventing reintroduction of transmission in Dhofar, at least until all neighbouring endemic countries will have achieved the same goal [2]. The experience accumulated by health authorities of Oman in controlling and monitoring schistosomiasis for a period of over 30 years will certainly prove useful in either endeavor.

Box 1 Timeline of facts and activities related to schistosomiasis in Oman

1970s/1980s – Malacological investigations define geographical areas of Oman where snail intermediate hosts of Schistosoma spp. can be found

1979 – First cases of S. mansoni infection detected in Dhofar Governorate, Oman

1982 – Systematic screening of water bodies in Dhofar Governorate for presence of B. arabica; active surveillance by systematic stool examination is initiated

1983 – An inter-sectorial control strategy is launched by the Ministry of Health

1990s – Incidence of infection reaches very low levels

2001 – Active surveillance by systematic serological surveys is initiated

2003 – An elimination strategy relying on mass treatment is launched following a recrudescence in transmission

2007 – The last parasitological autochthonous case is detected through passive surveillance; mass chemotherapy with praziquantel is initiated

2010 – The last parasitological autochthonous case is detected through active surveillance

2012 – Active surveillance by systematic stool examination is discontinued

2014 – Mass chemotherapy with praziquantel is discontinued

2015 – Active surveillance by systematic serological surveys is suspended while MoH is planning the implementation of surveys aimed at confirming interruption of transmission

Abbreviations

CCA: 

Circulating cathodic antigen

IHA: 

Indirect Haemagglutination Assay

MoH: 

Ministry of Health

WHA: 

World Health Assembly

WHO: 

World Health Organization

Declarations

Acknowledgments

The authors sincerely acknowledge the health staff who contributed to implementation of field activities, and the populations of Dhofar Governorate for taking part in the surveys. Antonio Montresor is acknowledged for help in the revision of the manuscript.

Funding

Field activities reported in this article were implemented by the Ministry of Health of Oman over a period of 33 years, through national budget allocations. In different capacities, the Authors invested their time in designing and carrying out such activities, collecting, cleaning and analyzing data, and drafting the manuscript as part of their professional responsibilities, without any financial compensation.

Availability of data and materials

Data supporting the conclusion of this paper are part of a large dataset compiled over the years by the Ministry of Health of Oman. Consequently, they are not part of this paper. They can be made available on request, by contacting the Directorate General for Disease Surveillance & Control, Ministry of Health, Muscat, Oman.

Authors’ contributions

Data were generated over the years by the monitoring & evaluation system of the Ministry of Health of Oman, with technical support from WHO. In the most recent years, IAA, SAA1 and MS also conceived, supervised and directed implementation of the surveys, while SLG, SAA2 and KAM were responsible for their implementation. AG and AFG contributed by analyzing and interpreting data. All Authors contributed equally to the manuscript. All authors read and approved the final manuscript.

Authors’ information

IAA is Director, Communicable Disease Surveillance and Control, MoH, Oman; SAA1 is Director General, Disease Surveillance & Control, MoH, Oman; MS is an Advisor in the Undersecretary Office, MoH, Oman; SLG and SAA2 are Regional Epidemiologist at the Directorate General of Health Services, Dhofar Governorate, MoH, Oman; KAM is Director General of Health Services, Dhofar Governorate, MoH, Oman; AG is Medical Officer in the Department of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland; AFG is Regional Adviser for Neglected Tropical Diseases in the Division of Communicable Diseases, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

All authors have approved the manuscript for submission.

Ethics approval and consent to participate

Activities reported in this article were ethically cleared by the Ministry of Health, Oman, and were implemented as part of the routine interventions aimed at monitoring and evaluating public-health, disease-control measures carried out by the national authorities over a period of 33 years. School heads and children’s parents or guardians were briefed about the aims of such activities, and they orally consented to children taking part in them. Children were also briefed and none of them was forced to participate in the activities described in the article.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Directorate General for Disease Surveillance & Control, Ministry of Health
(2)
Undersecretary Office, Ministry of Health
(3)
Directorate General of Health Services, Dhofar Governorate, Ministry of Health
(4)
Department of Neglected Tropical Diseases, World Health Organization
(5)
Division of Communicable Diseases, World Health Organization Regional Office for the Eastern Mediterranean, Shara’a Abdul Razzak Al Sanhouri

References

  1. Heymann DL. Control of Communicable Diseases Manual. 20th ed. Washington: American Public Health Association Press; 2015.View ArticleGoogle Scholar
  2. WHO. Schistosomiasis, Progress Report 2001–2011 and Strategic Plan 2012–2020. Geneva: WHO; 2013.Google Scholar
  3. WHO. Elimination of schistosomiasis, WHA Resolution 65.21. Geneva: WHO; 2012.Google Scholar
  4. Lotfy WM, Alsaqabi SM. Human schistosomiasis in the kingdom of Saudia Arabia: a review. J Med Res Inst. 2010;31(1):1–6.Google Scholar
  5. Hotez PJ, Savioli L, Fenwick A. Neglected tropical diseases in the Middle East and North Africa: review of their prevalence, distribution and opportunities for control. PLoS Negl Trop Dis. 2012;6(2):e1475.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Idris MA, Shaban M, Richter J, Moné H, Mouahid G, Ruppel A. Emergence of infections with Schistosoma mansoni in the Dhofar Governorate, Oman. Acta Trop. 2003;88(2):137–44.View ArticlePubMedGoogle Scholar
  7. Scrimgeour EM, Ahmed A, Sallam J, Khoul R, Al-Dhahry SH, Daar AS, et al. Schistosomiasis in patients in the Sultanate of Oman. Ann Saudi Med. 2001;21(3–4):170–3.PubMedGoogle Scholar
  8. Shaban MM. Role of organisational cooperation in schistosomiasis eradication in Dhofar Governorate. Oman Med J. 1995;12:17–9.Google Scholar
  9. Wright CA, Brown DS. The freshwater Mollusca of Dhofar. J Oman Stud Spec Rep. 1980;2:97–102.Google Scholar
  10. Brown DS, Gallagher MD. Freshwater snails of Oman, South Eastern Arabia. Hydrobiologia. 1985;127:125–49.View ArticleGoogle Scholar
  11. Idris MA, Ruppel A, Numrich P, Eschlbeck A, Shaban MA, Diesfeld HJ. Schistosomiasis in the southern region of Oman: vector snails and serological identification of patients in several locations. J Trop Med Hyg. 1994;97(4):205–10.PubMedGoogle Scholar
  12. Brown DS, Gallagher MD, Knowles RJ, Paltrinieri AB. Bulinus wrighti, potential snail host for Schistosoma haematobium in northern Oman. Trans R Soc Trop Med Hyg. 1985;79(1):136–7.View ArticlePubMedGoogle Scholar
  13. Doumenge JP, Mott KE, Cheung C, Villenave D, Chapuis O, Perrin MF, Reaud-Thomas G. Atlas of the global distribution of schistosomiasis. Bordeaux: Presses Universitaires, 1987, Geneva: WHO.
  14. Ministry of Health of the Sultanate of Oman. Annual Health Reports. Muscat: 1990–2014
  15. Moné H, Gabriel M, Shaban MA, Al Jabri AA, Boissier J, Ruppel A, Idris MA. Ecological and Molecular studies on emerging schistosomiasis in Dhofar Governorate, Sultanate of Oman. Trop Med Int Health. 2003;8(3):269–76.View ArticlePubMedGoogle Scholar
  16. Ministry of Health of the Sultanate of Oman. Schistosomiasis, Manual on Communicable Disease Surveillance & Control, 2edn. MoH, 2005: 92–94.
  17. WHO. Inter-country Meeting on Strategies to Eliminate Schistosomiasis from the Eastern Mediterranean Region. Muscat, Oman, 6–8 November 2007. Report. Available online at: http://www.who.int/schistosomiasis/resources/EMRO_report_Schistosomiasis.pdf. Accessed 1 Sept 2016.
  18. WHO. Bench Aids for the diagnosis of intestinal parasites. Geneva: WHO; 1994.Google Scholar
  19. Deelder AM, Eveleigh PC. An indirect haemagglutination reaction for the demonstration of Schistosoma mansoni circulating anodic antigen. Trans R Soc Trop Med Hyg. 1978;72(2):178–87.View ArticlePubMedGoogle Scholar
  20. van Lieshout L, Polderman AM, Deelder AM. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop. 2000;77(1):69–80.View ArticlePubMedGoogle Scholar
  21. Hamburger J, Abbasi I, Kariuki C, Wanjala A, Mzungu E, Mungai P, Muchiri E, King CH. Evaluation of loop-mediated isothermal amplification suitable for molecular monitoring of schistosome-infected snails in field laboratories. Am J Trop Med Hyg. 2013;88(2):344–51.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Colley DG, Binder S, Campbell C, King CH, Tchuem-Tchuenté LA, N’Goran EK, Erko B, Karanja DM, Kabatereine NB, van Lieshout L, Rathbun S. A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni. Am J Trop Med Hyg. 2013;88(3):426–32.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Zhu HQ, Xu J, Zhu R, Cao CL, Bao ZP, Yu Q, Zhang LJ, Xu XL, Feng Z, Guo JG. Comparison of the miracidium hatching test and modified Kato-Katz method for detecting Schistosoma japonicum in low prevalence areas of China. Southeast Asian J Trop Med Public Health. 2014;45(1):20–5.PubMedGoogle Scholar

Copyright

© The Author(s). 2016